These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9800 related articles for article (PubMed ID: 1542095)

  • 1. Novel anticancer prodrugs of butyric acid. 2.
    Nudelman A; Ruse M; Aviram A; Rabizadeh E; Shaklai M; Zimrah Y; Rephaeli A
    J Med Chem; 1992 Feb; 35(4):687-94. PubMed ID: 1542095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivatives of butyric acid as potential anti-neoplastic agents.
    Rephaeli A; Rabizadeh E; Aviram A; Shaklai M; Ruse M; Nudelman A
    Int J Cancer; 1991 Aug; 49(1):66-72. PubMed ID: 1874573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of tributyrin in murine melanoma model.
    Giermasz A; Nowis D; Jalili A; Basak G; Marczak M; Makowski M; Czajka A; Młynarczuk I; Hoser G; Stok osa T; Lewandowski S; Jakóbisiak M
    Cancer Lett; 2001 Mar; 164(2):143-8. PubMed ID: 11179828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug.
    Rabizadeh E; Shaklai M; Nudelman A; Eisenbach L; Rephaeli A
    FEBS Lett; 1993 Aug; 328(3):225-9. PubMed ID: 8348968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selectivty and anti-metastatic activity of oral bioavailable butyric acid prodrugs.
    Rephaeli A; Entin-Meer M; Angel D; Tarasenko N; Gruss-Fischer T; Bruachman I; Phillips DR; Cutts SM; Haas-Kogan D; Nudelman A
    Invest New Drugs; 2006 Sep; 24(5):383-92. PubMed ID: 16502348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutual prodrug of retinoic and butyric acids with enhanced anticancer activity.
    Nudelman A; Rephaeli A
    J Med Chem; 2000 Jul; 43(15):2962-6. PubMed ID: 10956204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retinoid/butyric acid prodrug overcomes retinoic acid resistance in leukemias by induction of apoptosis.
    Mann KK; Rephaeli A; Colosimo AL; Diaz Z; Nudelman A; Levovich I; Jing Y; Waxman S; Miller WH
    Mol Cancer Res; 2003 Oct; 1(12):903-12. PubMed ID: 14573791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
    Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
    Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butyric monosaccharide ester-induced cell differentiation and anti-tumor activity in mice. Importance of their prolonged biological effect for clinical applications in cancer therapy.
    Pouillart P; Cerutti I; Ronco G; Villa P; Chany C
    Int J Cancer; 1991 Aug; 49(1):89-95. PubMed ID: 1874576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
    Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
    J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an HL-60 leukemic cell line.
    Aviram A; Zimrah Y; Shaklai M; Nudelman A; Rephaeli A
    Int J Cancer; 1994 Mar; 56(6):906-9. PubMed ID: 8119779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prodrugs of butyric acid. Novel derivatives possessing increased aqueous solubility and potential for treating cancer and blood diseases.
    Nudelman A; Gnizi E; Katz Y; Azulai R; Cohen-Ohana M; Zhuk R; Sampson SR; Langzam L; Fibach E; Prus E; Pugach V; Rephaeli A
    Eur J Med Chem; 2001 Jan; 36(1):63-74. PubMed ID: 11231050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anticancer prodrugs of butyric acid AN-7 and AN-9, possess antiangiogenic properties.
    Blank-Porat D; Gruss-Fischer T; Tarasenko N; Malik Z; Nudelman A; Rephaeli A
    Cancer Lett; 2007 Oct; 256(1):39-48. PubMed ID: 17611019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formaldehyde-releasing prodrugs in combination with adriamycin can overcome cellular drug resistance.
    Cutts SM; Nudelman A; Pillay V; Spencer DM; Levovich I; Rephaeli A; Phillips DR
    Oncol Res; 2005; 15(4):199-213. PubMed ID: 17822280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of butanoate, retinoate, and bis(2,2,2-trichloroethyl)phosphate derivatives of 5-fluoro-2'-deoxyuridine and 2',5-difluoro-2'-deoxyuridine as potential dual action anticancer prodrugs.
    Xia Z; Wiebe LI; Miller GG; Knaus EE
    Arch Pharm (Weinheim); 1999 Aug; 332(8):286-94. PubMed ID: 10489539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic-acid butyric esters as promising antineoplastic agents in human lung carcinoma: a preclinical study.
    Coradini D; Pellizzaro C; Abolafio G; Bosco M; Scarlata I; Cantoni S; Stucchi L; Zorzet S; Turrin C; Sava G; Perbellini A; Daidone MG
    Invest New Drugs; 2004 Aug; 22(3):207-17. PubMed ID: 15122068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of L-2-oxothiazolidine-4-carboxylate on the cytotoxic activity and toxicity of cyclophosphamide in mice bearing B16F10 melanoma liver metastases.
    del Olmo M; Alonso-Varona A; Castro B; Calle Y; Bilbao P; Palomares T
    Melanoma Res; 2000 Apr; 10(2):103-12. PubMed ID: 10803710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells.
    Zimra Y; Wasserman L; Maron L; Shaklai M; Nudelman A; Rephaeli A
    J Cancer Res Clin Oncol; 1997; 123(3):152-60. PubMed ID: 9119880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel multifunctional acyloxyalkyl ester prodrugs of 5-aminolevulinic acid display improved anticancer activity independent and dependent on photoactivation.
    Berkovitch G; Doron D; Nudelman A; Malik Z; Rephaeli A
    J Med Chem; 2008 Dec; 51(23):7356-69. PubMed ID: 19007111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
    Burres NS; Clement JJ
    Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 490.